Effects of exogenous ubiquitin in lethal endotoxemia

Surgery

Volumn 135, Issue 5, 2004, Pages 536-543

  Majetschak, Matthias ^a   Cohn, Stephen M ^b   Nelson, Jacob A ^b   Burton, Elizabeth H ^b   Obertacke, Udo ^b   Proctor, Kenneth G ^b  

^a JACKSON MEMORIAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN;

ARTICLE; ASSISTED VENTILATION; CONCENTRATION RESPONSE; CYTOKINE PRODUCTION; EDEMA; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; HUMAN; IN VITRO STUDY; IN VIVO CULTURE; NONHUMAN; PRIORITY JOURNAL; REDUCTION; SWINE;

EID: 2342503177     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2003.09.006     Document Type: Article

References (30)

1. Özkaynak E, Finley D, Varshavsky A. The yeast ubiquitin gene: head-to-tail repeats encoding a polyubiquitin precursor protein. Nature 1984;312:663-6.
2. Goldstein GM, Scheid U, Hammerling DH, Schlesinger DH, Niall HD, Boyse EA. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci USA 1975;72:11-5.
3. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67:425-79.
4. Pickart CM. Ubiquitin enters the new millennium. Meeting review. Molecular Cell 2001;8:499-504.
5. Hasselgren P-O, Fischer JE. The ubiquitin-proteasome pathway. Ann Surg 1997;225:307-16.
6. Seufert W, Jentsch S. In vivo function of the proteasome in the ubiquitin pathway. EMBO J 1992;11:3077-80.
7. Goldstein GM, Scheid U, Hammerling DH, Schlesinger DH, Niall HD, Boyse EA. Ubiquitin-mediated processing of NF-kappa B transcriptional activator precursor p105. Reconstitution of a cell-free system and identification of the ubiquitin-carrier protein, E2, and a novel ubiquitin-protein ligase, E3, involved in conjugation. J Biol Chem 1995;270:21707-14.
8. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-kB1 precursor protein and the activation of NF-kB. Cell 1994;78:773-85.
9. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci USA 1995;92:11259-63.
10. Jesenberger V, Jentsch S. Deadly encounter: ubiquitin meets apoptosis. Nat Rev Mol Cell Biol 2002;3:112-21.
11. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immun 2002;3:20-6.
12. Pancre V, Pierce RJ, Fournier F, Mehtali M, Delanoye A, Capron A, et al. Effect of ubiquitin on platelet functions: possible identity with platelet activity suppressive lymphokine (PASL). EurJ Immunol 1991;21:2735-41.
13. Daino H, Shibayama H, Machii T, Kitani T. Extracellular ubiquitin regulates the growth of human hematopoietic cell. Biochem Biophys Res Commun 1996;223:226-8.
14. Nakamura M, Nagata T, Xavier M, Tanigawa Y. Ubiquitin-like polypeptide inhibits the IgE response of lipopolysaccharide-activated B cells. Int Immunol 1996;8:1659-65.
15. Daino H, Matsumura I, Takada K, Odajima J, Tanaka H, Ueda S, et al. Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent haematopoetic cells. Blood 2000;95:2577-85.
16. Majetschak M, Krehmeier U, Bardenheuer M, Denz C, Quintel M, Voggenreiter G, et al. Extracellular ubiquitin inhibits the TNFα response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness. Blood 2003;101:1882-90.
17. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
18. Kieffer A-E, Goumon Y, Ruh O, Chasserot-Golaz S, Nullans G, Gasnier C, et al. The N- and C-terminal fragments of ubiquitin are important for the antimicrobial activities. FASEB J published online Feb 19, 2003, 10.1096/fj.02-0699fje
19. Asseman C, Pancre V, Delanoye A, Capron A, Auriault C. A radioimmunoassay for the quantification of human ubiquitin in biological fluids: application to parasitic and allergic diseases. J Immunol Methods 1994;173:93-101.
20. Takagi M, Yamauchi M, Toda G, Takada, Hirakawa T, Ohkawa K. Serum ubiquitin levels in patients with alcoholic liver disease. Alcohol Clin Exp Res 1999;23:76-80.
21. Takada K, Nasu H, Hibi N, Tsukada Y, Shibasaki T, Fujise K, et al. Serum concentrations of free ubiquitin and multi-ubiquitin chains. Clin Chem 1997;43:1188-95.
22. Schade FU, Flach R, Flohé S, Majetschak M, Kreuzfelder E, Dominguez-Fernandez E, et al. Endotoxin tolerance. In: Brade H, Morrison DC, Opal S, Vogel S, editors. Endotoxins in health and disease New York: Marcel Dekker, 1999. p. 751-6.
23. Tracey KJ. The inflammatory reflex. Nature 2002;420:853-9.
24. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 1991;88:1747-54.
25. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 1995;85:1341-7.
26. Adrie C, Adib-Conquy M, Laurent I, Monchi M, Vinsonneau C, Fitting C, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation 2002;106:562-8.
27. Dickneite G, Leithauser B. Influence of antithrombin III on coagulation and inflammation in porcine septic shock. Arterioscler Thromb Vasc Biol 1999;19:1566-72.
28. Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:1838-42.
29. Yao YM, Sheng ZY, Tian HM, Yu Y, Wang YP, Yang HM, et al. The association of circulating endotoxaemia with the development of multiple organ failure in burned patients. Burns 1995;21:255-8.
30. Caradonna L, Amati L, Lella P, Jirillo E, Caccavo D. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease. Am J Gastroenterol 2000;95:1495-502.